This compound is a tert-butyl carbamate derivative used as a pharmaceutical intermediate in the manufacturing of upadacitinib. It features a pyrrolo[2,3-b]pyrazine core with a 4-methylphenylsulfonyl substituent and a tert-butyloxycarbonyl-protected amine group.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Carbamic acid, N-[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]-, ethyl ester
pharmaceutical intermediate
5-Bromo-4,7-diazaindole
pharmaceutical intermediate
(R)-1-(3-Chlorophenyl)ethanol
pharmaceutical intermediate
Ixazomib Impurity 1
pharmaceutical intermediate
N,N',N''-((((1R,1'R,1''R)-(1,3,5,2,4,6-trioxatriborinane-2,4,6-triyl)tris(3-methylbutane-1,1-diyl))tris(azanediyl))tris(2-oxoethane-2,1-diyl))tris(2,5-dichlorobenzamide)
pharmaceutical intermediate
Methyl 1H-indole-2-carboxylate
pharmaceutical intermediate
2-Bromo-5-(4-methylbenzene-1-sulfonyl)-5H-pyrrolo[2,3-b]pyrazine
pharmaceutical intermediate
tert-butyl N-[5-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyrazin-2-yl]carbamate
NTMJGYRFMXFNIC-UHFFFAOYSA-N
CC1=CC=C(C=C1)S(=O)(=O)N2C=CC3=NC(=CN=C32)NC(=O)OC(C)(C)C
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.